Keyphrases
Indonesia
76%
Asia
49%
Antiretroviral Therapy
45%
Combined Antiretroviral Therapy (cART)
43%
COVID-19
40%
Pada
34%
AIDS/HIV
28%
Jakarta
26%
Confidence Interval
25%
Medical Students
24%
Systemic Lupus Erythematosus
20%
Primary Immunodeficiency
20%
Perinatally Acquired HIV
18%
Undergraduate Medical Students
18%
HIV Care
18%
Assessment Questionnaire
18%
Evidence-based Case Report
18%
Site Assessment
18%
Loss-to-follow-up
18%
Genetic Test
18%
Lupus
17%
Antiretroviral Therapy Initiation
16%
People Living with HIV (PLHIV)
15%
CD4%
14%
Modul
13%
COVID-19 Pandemic
12%
Global Epidemiology
12%
Perinatally HIV-infected Adolescents
12%
Telemedicine
11%
Viral Load Monitoring
11%
Asian children
11%
Antiretroviral
11%
Children Living with HIV
11%
Virological Failure
11%
Weight-for-age z Score
11%
Self-isolation
11%
Treatment Outcome
11%
Tertiary Referral Hospital
10%
Multisystem Inflammatory Syndrome in children (MIS-C)
10%
South-East Asia
10%
Tertiary Hospital
10%
Service Delivery
10%
Monitoring Module
9%
Plasma Viral Load
9%
Transition to Practice
9%
Temporal Change
9%
Changing Criterion
9%
HIV-infected children
9%
Regional Survey
9%
Severe Malnutrition
9%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Antiretroviral Therapy
61%
Lupus Erythematosus
28%
COVID-19
28%
Immune Deficiency
22%
Cohort Effect
20%
Systemic Lupus Erythematosus
18%
Diseases
16%
Human Immunodeficiency Virus Infection
13%
Pediatrics
12%
Retrospective Cohort Study
11%
Retrospective Study
11%
Serositis
11%
Patient Referral
10%
Kaposi Sarcoma
9%
Viremia
9%
Treatment Interruption
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Vitamin D
9%
Isotopes of Calcium
9%
Clinical Feature
9%
Lactobacillus reuteri
9%
Placebo
9%
Monotherapy
9%
Rheumatology
9%
Cytomegalovirus Infection
9%
Iron Deficiency
9%
Cyanotic Heart Defect
9%
Reticulocyte
9%
Hypochromic Anemia
9%
Dysplasia
9%
Congenital Nephrotic Syndrome
9%
Polymerase Chain Reaction
9%
Nephrotic Syndrome
9%
Prevalence
9%
Midazolam
8%
Cytomegalovirus
7%
Short Stature
7%
Fatality
7%
Mortality Rate
7%
Probiotics
7%
Human Development
7%
Hazard Ratio
6%
Strengths and Difficulties Questionnaire
5%